UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027539
Receipt number R000031443
Scientific Title Automatic 3D-construction of hepatocellular carcinoma
Date of disclosure of the study information 2017/05/30
Last modified on 2022/12/03 10:14:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Automatic 3D-construction of hepatocellular carcinoma

Acronym

3D-HCC

Scientific Title

Automatic 3D-construction of hepatocellular carcinoma

Scientific Title:Acronym

3D-HCC

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To construct 3D-HCC images automatically, we developed a new computer program, and we investigated the validity of the program by comparing the developed images with those of resection specimens.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The similarities between a cut-surface of 3D-HCC and a real cut-surface images of resected HCC.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who were diagnosed as overt HCC by enhanced CT and had liver resection.

Key exclusion criteria

Patients with allergy of contrast material. Patients with no indication of surgery.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hisashi
Middle name
Last name Nakayama

Organization

Nihon University School of Medicine

Division name

Department of Digestive Surgery

Zip code

1738610

Address

30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan

TEL

03-3972-8111

Email

nakayama.hisashi@nihon-u.ac.jp


Public contact

Name of contact person

1st name Hisashi
Middle name
Last name Nakayama

Organization

Nihon University School of Medicine

Division name

Department of Digestive Surgery

Zip code

1738610

Address

30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan

TEL

03-3972-8111

Homepage URL


Email

nakayama.hisashi@nihon-u.ac.jp


Sponsor or person

Institute

Department of Digestive Surgery, Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Digestive Surgery, Nihon University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Nihon University School of Medicine

Address

30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan

Tel

0339728111

Email

med.itabashi.chiken@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本大学医学部消化器外科(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 30 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000031443&t

Publication of results

Unpublished


Result

URL related to results and publications

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000031443&t

Number of participants that the trial has enrolled

300

Results

under observation

Results date posted

2022 Year 12 Month 03 Day

Results Delayed

Delay expected

Results Delay Reason

Requires detailed follow-up

Date of the first journal publication of results


Baseline Characteristics

Liver cancer patients scheduled for hepatectomy

Participant flow

Blood sampling and imaging every 3 months

Adverse events

no

Outcome measures

Ongoing follow-up

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 05 Month 01 Day

Date of IRB

2013 Year 04 Month 26 Day

Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Accumulation of examination data, and analysis are ongoing.


Management information

Registered date

2017 Year 05 Month 30 Day

Last modified on

2022 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031443


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name